-
1
-
-
0034005755
-
The post-prandial state and cardiovascular disease: Relevance to diabetes mellitus
-
Ceriello A. The post-prandial state and cardiovascular disease: Relevance to diabetes mellitus. Diabetes Metab Res Rev 2000;16:125-132.
-
(2000)
Diabetes Metab Res Rev
, vol.16
, pp. 125-132
-
-
Ceriello, A.1
-
2
-
-
0036021977
-
Postprandial peaks as a risk factor for cardiovascular disease: Epidemiological perspectives
-
Bonora E. 2002. Postprandial peaks as a risk factor for cardiovascular disease: Epidemiological perspectives. Int J Clin Pract Suppl 2002;129:5-11.
-
(2002)
Int J Clin Pract Suppl
, vol.129
, pp. 5-11
-
-
Bonora, E.1
-
3
-
-
0034761311
-
Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat
-
Pandolfi A, Giaccari A, Cilli C, et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 2001;38:71-76.
-
(2001)
Acta Diabetol
, vol.38
, pp. 71-76
-
-
Pandolfi, A.1
Giaccari, A.2
Cilli, C.3
-
4
-
-
28444484666
-
Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM
-
Coppola G, Corrado E, Muratori I, et al. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Cardiol 2006;106:16-20.
-
(2006)
Int J Cardiol
, vol.106
, pp. 16-20
-
-
Coppola, G.1
Corrado, E.2
Muratori, I.3
-
5
-
-
33846992271
-
C-reactive protein and cardiovascular risk in the metabolic syndrome and type 2 diabetes: Controversy and challenge
-
Capuzzi DM, Freeman JS. C-reactive protein and cardiovascular risk in the metabolic syndrome and type 2 diabetes: Controversy and challenge. Clin Diabetes 2007;25:16-22.
-
(2007)
Clin Diabetes
, vol.25
, pp. 16-22
-
-
Capuzzi, D.M.1
Freeman, J.S.2
-
6
-
-
0344013592
-
Is C-reactive protein a marker of inflammation?
-
Dupuy AM, Terrier N, Senecal L, et al. Is C-reactive protein a marker of inflammation? Nephrologie 2003;24:337-341.
-
(2003)
Nephrologie
, vol.24
, pp. 337-341
-
-
Dupuy, A.M.1
Terrier, N.2
Senecal, L.3
-
7
-
-
38149021434
-
Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3
-
Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008;28:1-13.
-
(2008)
J Clin Immunol
, vol.28
, pp. 1-13
-
-
Mantovani, A.1
Garlanda, C.2
Doni, A.3
Bottazzi, B.4
-
8
-
-
0032943709
-
C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
-
Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 972-978
-
-
Yudkin, J.S.1
Stehouwer, C.D.2
Emeis, J.J.3
Coppack, S.W.4
-
9
-
-
0034604248
-
Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
-
Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47.
-
(2000)
Circulation
, vol.102
, pp. 42-47
-
-
Festa, A.1
D'Agostino Jr., R.2
Howard, G.3
Mykkanen, L.4
Tracy, R.P.5
Haffner, S.M.6
-
10
-
-
0035908632
-
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
-
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 2001;286:327-334.
-
(2001)
J Am Med Assoc
, vol.286
, pp. 327-334
-
-
Pradhan, A.D.1
Manson, J.E.2
Rifai, N.3
Buring, J.E.4
Ridker, P.M.5
-
11
-
-
33749176140
-
C-reactive protein in hypertension: Clinical significance and predictive value
-
Schillaci G, Pirro M. C-reactive protein in hypertension: Clinical significance and predictive value. Nutr Metab Cardiovasc Dis 2006;16:500-508.
-
(2006)
Nutr Metab Cardiovasc Dis
, vol.16
, pp. 500-508
-
-
Schillaci, G.1
Pirro, M.2
-
12
-
-
23844505240
-
Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker
-
Devaraj S, O'Keefe G, Jialal I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab 2005;90:4549-4554.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 4549-4554
-
-
Devaraj, S.1
O'Keefe, G.2
Jialal, I.3
-
13
-
-
15244348518
-
The origins of age-related proinflammatory state
-
Ferrucci L, Corsi A, Lauretani F, et al. The origins of age-related proinflammatory state. Blood 2005;105:2294-2299.
-
(2005)
Blood
, vol.105
, pp. 2294-2299
-
-
Ferrucci, L.1
Corsi, A.2
Lauretani, F.3
-
14
-
-
33845663688
-
High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro
-
Iwasaki Y, Kambayashi M, Asai M, Yoshida M, Nigawara T, Hashimoto K. High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J Diabetes Complications 2007;21:56-62.
-
(2007)
J Diabetes Complications
, vol.21
, pp. 56-62
-
-
Iwasaki, Y.1
Kambayashi, M.2
Asai, M.3
Yoshida, M.4
Nigawara, T.5
Hashimoto, K.6
-
15
-
-
0033545342
-
Acute-phase proteins and other systemic responses to inflammation
-
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
-
(1999)
N Engl J Med
, vol.340
, pp. 448-454
-
-
Gabay, C.1
Kushner, I.2
-
16
-
-
1842505521
-
C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases
-
Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 2004;62:499-506.
-
(2004)
Med Hypotheses
, vol.62
, pp. 499-506
-
-
Li, J.J.1
Fang, C.H.2
-
17
-
-
33644693579
-
Liver markers and development of the metabolic syndrome: The insulin resistance atherosclerosis study
-
Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino Jr RB, Haffner SM. Liver markers and development of the metabolic syndrome: The insulin resistance atherosclerosis study. Diabetes 2005;54:3140-3147.
-
(2005)
Diabetes
, vol.54
, pp. 3140-3147
-
-
Hanley, A.J.1
Williams, K.2
Festa, A.3
Wagenknecht, L.E.4
D'Agostino Jr., R.B.5
Haffner, S.M.6
-
18
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
-
(2000)
N Engl J Med
, vol.342
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
Rifai, N.4
-
19
-
-
33645338452
-
The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan
-
Oda E, Oohara K, Abe A, et al. The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan. Circ J 2006;70:384-388.
-
(2006)
Circ J
, vol.70
, pp. 384-388
-
-
Oda, E.1
Oohara, K.2
Abe, A.3
-
20
-
-
34548739086
-
Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile, 2005
-
Palomo I, Icaza G, Mujica V, et al. Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile, 2005. Rev Med Chil 2007;135:904-912.
-
(2007)
Rev Med Chil
, vol.135
, pp. 904-912
-
-
Palomo, I.1
Icaza, G.2
Mujica, V.3
-
21
-
-
0032162184
-
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
-
National Institute of Health
-
National Institute of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res 1998;6:51S-209S.
-
(1998)
Obes Res
, vol.6
-
-
-
22
-
-
0038460302
-
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
-
National Institute of Health
-
National Institute of Health. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. J Am Med Assoc 2003;289:2560-2572.
-
(2003)
J Am Med Assoc
, vol.289
, pp. 2560-2572
-
-
-
23
-
-
40349084011
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association (ADA)
-
American Diabetes Association (ADA). Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55-S60.
-
(2008)
Diabetes Care
, vol.31
-
-
-
24
-
-
39749110640
-
Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: Results from the Monica/Kora Augsburg Cohort Study, 1984-1998
-
Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: Results from the Monica/Kora Augsburg Cohort Study, 1984-1998. Clin Chem 2008;54:335-342.
-
(2008)
Clin Chem
, vol.54
, pp. 335-342
-
-
Koenig, W.1
Khuseyinova, N.2
Baumert, J.3
Meisinger, C.4
-
25
-
-
25644437166
-
Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: The Hisayama Study
-
Doi Y, Kiyohara Y, Kubo M, et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: The Hisayama Study. Diabetes Care 2005;28:2497-2500.
-
(2005)
Diabetes Care
, vol.28
, pp. 2497-2500
-
-
Doi, Y.1
Kiyohara, Y.2
Kubo, M.3
-
26
-
-
13144253218
-
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle
-
Hayden MR, Tyagi SC. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond) 2004;1:10.
-
(2004)
Nutr Metab (Lond)
, vol.1
, pp. 10
-
-
Hayden, M.R.1
Tyagi, S.C.2
|